Page 2 - வெர்னான் பெர்னார்டினோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Cassava: Alzheimer Treatment s Progress Merits a New Price Target
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Cassava: Potential Alzheimer Treatment Opens Door for Lucrative Licensing Deal
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Biotechs With Massive Upside [BioCryst Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., AbbVie Inc]
Everybody knows that biotech ideas can become huge gainers for investors, but understanding the technology platforms, the unmet needs and the valuations can be daunting, especially in spaces where a number of players are developing products. In this interview with
The Life Sciences Report, Vernon Bernardino of MLV & Co. brings some clarity and perspective to investors who could reap windfalls from small-cap names in which shareholder value has yet to be created and realized.
The Life Sciences Report: Vernon, up to 30 thousand (30K) people currently have a vital and pressing need for experimental therapeutic and immunization agents to protect them from the ongoing Ebola virus disease (EVD) outbreak in West Africa. That 30K is a conservative estimate, according to University of Oxford epidemiologist Oliver Brady, who wrote an op-ed piece for the World View column of
Novavax, Inc (NASDAQ:NVAX) - Novavax Strikes Another Coronavirus Vaccine Supply Deal: Where Does The Company s Program Stand?
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Here are the results:
Oppenheimer, Colin Rusch
As the roller coaster ride that was 2020 comes to an end, investors are wondering where the market goes from here. 2020 saw a global pandemic claim over a million lives and the resulting lockdowns send the U.S. economy into a recession, with unemployment rates surpassing levels witnessed during the Great Recession.
Amid the health crisis, cities throughout the U.S. faced protests that broke out in response to police violence. If that wasn t enough, 2020 bore witness to a highly contentious U.S. presidential election, in which Joe Biden ultimately defeated incumbent Donald Trump.